Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer

NCT02125617 · clinicaltrials.gov ↗

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Poor recruition

Conditions

Prostatic Neoplasms

Interventions

DRUG: Abiraterone
DRUG: Prednisolone

Sponsor

Kristoffer Rohrberg

Collaborators

[object Object]